Site icon Credence Turbine

Newborn Screening Market Size Expected To Acquire USD 1497.71 billion By 2030 At 8.50% Compound Annual Growth Rate

The latest market report published by Credence Research, Inc. “Global Newborn Screening Market: Growth, Future Prospects, and Competitive Analysis, 2017 – 2030”. The Global Newborn Screening Market generated revenue of around USD 846.1 billion in 2022 and is anticipated to grow a CAGR of over 8.50% during the forecast period from 2023 to 2030 to reach around USD 1497.71 billion in 2030.

Growing newborn screening programs, the rising prevalence of congenital diseases, rising revenues from government sectors for newborn screening, and developments in newborn screening technology all contribute to the market’s expansion. Moreover, government-administered newborn screening programs across the continent are predicted to significantly impact the growth of the newborn screening market, as numerous nations mandate newborn screening before hospital discharge.

The global newborn screening market is bifurcated into Product Type, Test Type, Technology, End User, and Geography. Based on product type, the market is categorized into Instrument and Consumables. On the basis of test type, the global market is segmented into Blood tests, Hearing screening tests, and Heart screening. Based on technology, the newborn screening market is categorized into Tandem Mass Spectrometry (TMS), Molecular Assays, Immunoassays and Enzymatic Assays, Hearing Screen Technology, Pulse Oximetry Screening Technology, and Others. The global market is segmented into Hospitals and Clinical laboratories based on end users. Based on geography, the market is segmented as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America was predicted to hold a significant proportion of the global newborn screening market in 2022. Due to the growing occurrence of congenital disorders and obligatory testing in all 50 states, North America maintained the largest market share for newborn screening. The newborn screening programme is strictly administered in every state in North America. State health officials in the U. S. have published free data and created websites to aid parents in coping with these disorders to raise awareness.

The newborn screening market has witnessed significant growth over the years, owing to the increasing prevalence of genetic disorders among newborns. Several key players are operating in this space, including PerkinElmer Inc., Bio-Rad Laboratories Inc., Natus Medical Incorporated, Masimo Corporation, and Medtronic plc. These companies offer a wide range of products such as blood spot test kits for detecting metabolic disorders, hearing screening devices for identifying hearing impairments in infants, and pulse oximeters for monitoring oxygen levels.

The newborn screening market is expected to experience significant growth worldwide due to various factors.

Why to Buy This Report-

Browse Full Report: https://www.credenceresearch.com/report/newborn-screening-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/essential-tremor-market

Related Report: https://www.credenceresearch.com/report/rare-inflammatory-disease-treatment-market

Browse Our Blog: https://www.linkedin.com/pulse/newborn-screening-market-expected-generate-revenue-usd-singh